CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

$79.71
-0.20 (-0.25%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +28.4% upside
Low Target $62.31
Average Target $102.33
High Target $121.34
Current Price $79.71
Current
$79.71
Target
$102.33
$62.31 $102.33 avg $121.34
Scenario Analysis
Bear Case
$62.31
-21.8%
Low target
Base Case
$102.33
+28.4%
Avg target
Bull Case
$121.34
+52.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$91.00
-12.4% from high
52-Week Low
$28.66
+178.1% from low
50-Day SMA
$53.13
+50.0% vs SMA
200-Day SMA
$69.00
+15.5% vs SMA
RSI (14)
26.0
Oversold
Target vs 52W High
$102.33
+12.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%